Pre-order Enquiry
Request Free Sample
Global Hyoscine-N-Butyl Bromide Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-14036941 | Publishing Date : 01-Apr-2019 | No. of pages : 104
Request Sample
Request Customization
Check Discounts
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms.
Scope of the Report:
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
The production of Hyoscine-N-Butyl Bromideis increased from 6.3 MT in 2012 to 6.9 MT in 2016, at a CARG 2.54%. The manufacturers are Boehringer-Ingelheim, Linnea, Alchem International and Alkaloids.
Boehringer-Ingelheim is the world leader with 77.62% of market share in 2016. Boehringer-Ingelheim produces both Hyoscine-N-Butyl Bromideis API and Buscopan. They mainly sale Buscopan in market and the revenue of Buscopan is 236 EUR million and the revenue of Hyoscine-N-Butyl Bromideis API is 30.2 million USD in 2016.
The worldwide market for Hyoscine-N-Butyl Bromide is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 57 million US$ in 2024, from 40 million US$ in 2019, according to a new study.
This report focuses on the Hyoscine-N-Butyl Bromide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Boehringer-Ingelheim
Linnea, Alchem International
Alkaloids
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Boehringer-Ingelheim
Linnea
Alchem International
Alkaloids
Market Segment by Applications, can be divided into
Oral
Injection
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyoscine-N-Butyl Bromide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hyoscine-N-Butyl Bromide, with price, sales, revenue and global market share of Hyoscine-N-Butyl Bromide in 2017 and 2018.
Chapter 3, the Hyoscine-N-Butyl Bromide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyoscine-N-Butyl Bromide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Hyoscine-N-Butyl Bromide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Hyoscine-N-Butyl Bromide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
It is used to treat pain and discomfort caused by abdominal cramps, menstrual cramps or other spasmodic activity in the digestive system. It is also effective at preventing bladder spasms.
Scope of the Report:
Hyoscine-N-Butyl Bromideis obtained from a species of the plant genus Duboisia. It is mainly classified as an antispasmodic, which means that it is a drug used to suppress of muscle spasms, or involuntary contractions.
The production of Hyoscine-N-Butyl Bromideis increased from 6.3 MT in 2012 to 6.9 MT in 2016, at a CARG 2.54%. The manufacturers are Boehringer-Ingelheim, Linnea, Alchem International and Alkaloids.
Boehringer-Ingelheim is the world leader with 77.62% of market share in 2016. Boehringer-Ingelheim produces both Hyoscine-N-Butyl Bromideis API and Buscopan. They mainly sale Buscopan in market and the revenue of Buscopan is 236 EUR million and the revenue of Hyoscine-N-Butyl Bromideis API is 30.2 million USD in 2016.
The worldwide market for Hyoscine-N-Butyl Bromide is expected to grow at a CAGR of roughly 6.0% over the next five years, will reach 57 million US$ in 2024, from 40 million US$ in 2019, according to a new study.
This report focuses on the Hyoscine-N-Butyl Bromide in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Boehringer-Ingelheim
Linnea, Alchem International
Alkaloids
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Boehringer-Ingelheim
Linnea
Alchem International
Alkaloids
Market Segment by Applications, can be divided into
Oral
Injection
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Hyoscine-N-Butyl Bromide product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Hyoscine-N-Butyl Bromide, with price, sales, revenue and global market share of Hyoscine-N-Butyl Bromide in 2017 and 2018.
Chapter 3, the Hyoscine-N-Butyl Bromide competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Hyoscine-N-Butyl Bromide breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Hyoscine-N-Butyl Bromide market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Hyoscine-N-Butyl Bromide sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
